Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nippon Kayaku Cancer Pain Relief Drug To Enter Phase II Development

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Nippon Kayaku and Kyukyu Pharmaceutical will start a Phase II trial in 2010 for NKQ-01, a fentanyl-containing oral patch for cancer pain relief. A Phase I trial conducted in Europe in 2006 has shown promising results. The two are aiming for a 2015 market launch. (Click here for more - Japanese language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072188

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel